NCT06412926View on ClinicalTrials.gov

A Study to Learn About How Much Emodepside Gets Absorbed in the Blood and How Food Affects Its Absorption When Given as a New Type of Tablet to Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

May 7, 2024

Primary Completion Date

August 27, 2024

Study Completion Date

August 27, 2024

Conditions
Soil-transmitted Helminth InfectionOnchocerciasis (River Blindness)
Interventions
DRUG

BAY 44-4400

Film-coated tablet, oral use

DRUG

BAY 44-4400

Film-coated tablet, oral use

Trial Locations (1)

89231

NUVISAN GmbH Neu-Ulm, Neu-Ulm

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT06412926 - A Study to Learn About How Much Emodepside Gets Absorbed in the Blood and How Food Affects Its Absorption When Given as a New Type of Tablet to Healthy Participants | Biotech Hunter | Biotech Hunter